Search Results - "Barnadas Molins, Agusti"

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial by Salvador Bofill, Javier, Moreno Anton, Fernando, Rodriguez Sanchez, Cesar Augusto, Galve Calvo, Elena, Hernando Melia, Cristina, Ciruelos Gil, Eva Maria, Vidal, Maria, Jiménez-Rodriguez, Begoña, De la Cruz Merino, Luis, Martínez Jañez, Noelia, Villanueva Vazquez, Rafael, de Toro Salas, Ruben, Anton Torres, Antonio, Alvarez Lopez, Isabel Manuela, Gavila Gregori, Joaquin, Quiroga Garcia, Vanesa, Vicente Rubio, Elena, De la Haba-Rodriguez, Juan, Gonzalez-Santiago, Santiago, Diaz Fernandez, Nieves, Barnadas Molins, Agusti, Cantos Sanchez de Ibargüen, Blanca, Delgado Mingorance, Juan Ignacio, Bellet Ezquerra, Meritxell, de Casa, Sonia, Gimeno, Asuncion, Martin, Miguel

“…Breast cancer is the most common malignancy and the second leading cause of cancer-related mortality in Spanish women. Ribociclib in combination with endocrine…”
Get full text

Brain metastases in colorectal cancer: prognostic factors and survival analysis by Del Carpio Huerta, Luis, Virgili Manrique, Anna Cristina, Szafranska, Justyna, Martin-Richard, Marta, Paez Lopez-Bravo, David, Sebio Garcia, Ana, Espinosa Mariscal, Iñigo, Gomila Pons, Paula, Andres Granyo, Marta, Barba Joaquin, Andres, Barnadas Molins, Agusti, Tobeña Puyal, Maria

“…Purpose Colorectal cancer (CRC) brain metastases (BM) are an uncommon and late event. We aim to investigate the impact of clinical factors, treatment…”
Get full text

Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study by DE CASTRO CARPEÑO, JAVIER, GASCÓN-VILAPLANA, PERE, TEJERINA, ANA MARIA CASAS-FERNÁNDEZ-DE, ANTÓN-TORRES, ANTONIO, LÓPEZ-LÓPEZ, RAFAEL, BARNADAS-MOLINS, AGUSTÍ, CRUZ-HERNÁNDEZ, JUAN JESÚS, MASSUTI-SUREDA, BARTOMEU, CAMPS-HERRERO, CARLOS, ARANDA-AGUILAR, ENRIQUE, LASERNA, FRANCISCO JOSÉ REBOLLO

“…Febrile neutropenia (FN) is one of the most common adverse events associated with myelosuppressive chemotherapy for cancer treatment. The objective of this…”
Get full text

Sequential designs and intermediate analysis in clinical research: size vs difficulty by Monleón-Getino, Toni, Barnadas-Molins, Agustí, Roset-Gamisans, Montserrat

“…Sequential design differs from other statistical designs used in clinical research in that the sample size is not fixed in advance but it varies depending on…”
Get more information

Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients by Alberola Candel, Vicente, Carrato Mena, Alfredo, Díaz-Rubio García, Eduardo, Gascón Vilaplana, Pere, González Barón, Manuel, Martín Jiménez, Miguel, Alba Conejo, Emilio, Cassinello Espinosa, Javier, Colomer, Ramon, Cruz Hernández, Juan Jesús, Barnadas i Molins, Agustí, Camps Herrero, Carlos, Casas Fernández de Tejerina, Ana Ma, Carulla Torrent, Joan, Constenla Figueiras, Manuel, Gavilá Gregori, Joaquin, Isla Casado, Ma. Dolores, Massuti Sureda, Bartomeu, Provencio Pulla, Mariano, Rodríguez Sánchez, César Augusto, Sanz Ortiz, Jaime

“…Treatment of anaemia is a very important aspect in the management of cancer patients. In order to carry out a consensus process about the use of erythropoietic…”
Get full text

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) by Schneeweiss, A., Puglisi, F., Peretz-Yablonski, T., Merot, J.-L., Miles, D., Coudert, Bruno, Errihani, Hassan, Dalenc, Florence, Barrett, Sophie, Beato, Carlos, Hu, Xichun, Perrin, Christophe, Ettl, Johannes, Li, Huiping, Cariello, Anna, Frassoldati, Antonio, Wronski, Andrzej, Menjón Beltrán, Salomón, Cicin, Irfan, Schmid, Peter, Juarez, Alejandro, Matos, Erika, Uslu, Ruchan, Wildiers, Hans, Bourgeois, Hugues, von Schumann, Raquel, Wojtukiewicz, Marek, Peron, Yann Izarzugaza, Wheatley, Duncan, De Boer, Richard, Jerusalem, Guy, Latini, Luciano, Barnadas Molins, Agusti, Martinez, Eduardo, Baird, Richard, McCarthy, Nicole, Greil, Richard, Juhasz-Boess, Ingolf, de la Cruz, Luis Ruiz, Del Val, Olga, Azribi, Fathi, Turner, Nicholas, Andrade, Jurandyr, Bernstein, Vanessa, Rayson, Daniel, Gennari, Alessandra, El-Saghir, Nagi, Kukulska, Monika, Pelaez, Ignacio, del Mar Gordon, Maria, Varughese, Mohini, Levitt, Nicola, Singer, Christian, Efremidou, Anna, Evron, Ella, Luigi, Cavanna, Garcia, Andres, Lopez Ceballos, Maria Helena, García, María, Arcediano, Alberto, McAdam, Karen, Humphreys, Alison, de Grève, Jacques, Joy, Anil, Sehdev, Sandeep, Kütner, Riina, Laplaige, Philippe, Christensen, Bernd, Fountzilas, Georgios, Fried, Georgeta, Giacobino, Alice, Bonetti, Andrea, Van der Velden, Annette, Vrijaldenhoven, Suzan, Andres Conejero, Raquel, Murias, Adolfo, Saura, Salvador, Poole, Christopher, Woodward, Natasha, Califaretti, Nadia, Jiang, Jun, Padrik, Peeter, Saarni, Outi, Genet, Dominique, Catala, Stéphanie, Facchini, Thomas, Repp, Roland, Schroeder, Willibald, Kahan, Zsuzsanna, Rosengarten, Ora, Alabiso, Oscar, Van de Wouw, Yes, Sousa, Gabriela, Jesús Florián Jerico, Marta Santisteban, Torrego, Juan Carlos, Rodriguez, Cesar, Llorca, Cristina, Galán, Antonio, Rodríguez, Robinson, Alonso, Isabel

“…Pertuzumab combined with trastuzumab and docetaxel is the standard first-line therapy for HER2-positive metastatic breast cancer, based on results from the…”
Get full text

Socio-economic impact on women diagnosed and treated for breast cancer: a cross-sectional study by Masià, J., Merchán-Galvis, Á., Salas, K., Requeijo, C., Cánovas, E., Quintana, M. J., Bonfill, X.

“…Introduction The increase in breast cancer survival poses a challenge for patients to be able to rejoin their professional and social life in very similar…”
Get full text

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs by Nogales, Vanesa, Reinhold, William C, Varma, Sudhir, Martinez-Cardus, Anna, Moutinho, Catia, Moran, Sebastian, Heyn, Holger, Sebio, Ana, Barnadas, Agusti, Pommier, Yves, Esteller, Manel

“…Platinum-derived drugs such as cisplatin and carboplatin are among the most commonly used cancer chemotherapy drugs, but very few specific molecular and…”
Get full text

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) by Bachelot, T, Ciruelos, E, Schneeweiss, A, Puglisi, F, Peretz-Yablonski, T, Bondarenko, I, Paluch-Shimon, S, Wardley, A, Merot, J-L, du Toit, Y, Easton, V, Lindegger, N, Miles, D

“…Pertuzumab combined with trastuzumab and docetaxel is the standard first-line therapy for HER2-positive metastatic breast cancer, based on results from the…”
Get full text

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs by Nogales, Vanesa, Reinhold, William C, Varma, Sudhir, Martínez Cardús, Anna, Moutinho, Cátia, Moran, Sebastian, Heyn, Holger, Sebio, Ana, Barnadas i Molins, Agustí, Pommier, Yves, Esteller, Manel

“…Platinum-derived drugs such as cisplatin and carboplatin are among the most commonly used cancer chemotherapy drugs, but very few specific molecular and…”
Get full text

Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a restrospective cohort study in Catalonia, Spain by Font, Rebeca, Espinàs Piñol, Josep Alfons, Gil Gil, M, Barnadas i Molins, Agustí, Ojeda, B, Tusquets, I, Seguí, M. A, Margelí, M, Arcusa, A, Prat Marín, Andrés, García, M, Borràs Andrés, Josep Maria

“…AIMS: To compare different methods in order to assess adherence and persistence with oral endocrine therapy in women diagnosed with breast cancer (BC) in…”
Get full text